(PDF) The HMG-CoA Reductase Inhibitor Atorvastatin

The HMG-CoA Reductase Inhibitor Atorvastatin Increases the Fractional Clearance Rate of Postprandial Triglyceride-Rich Lipoproteins in Miniature Pigs

Arteriosclerosis, Thrombosis, and Vascular Biology - United States

doi 10.1161/01.atv.18.12.1906

Full Text

Abstract

Available in full text

Categories

Cardiovascular Medicine

Date

December 1, 1998

Authors

John R. Burnett

P. Hugh R. Barrett

David B. Miller

Dawn E. Telford

Sandra J. Kleinstiver

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine

English

Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers

Circulation Journal

Cardiovascular Medicine

English

Features of the HMG 1 Subfamily of Genes Encoding HMG-CoA Reductase in Potato

Plant Molecular Biology

English

Risk Factors and Serum Cholesterol Concentrations in the Patients Given HMG-CoA Reductase Inhibitor, Pravastatin

Japanese Journal of Clinical Pharmacology and Therapeutics

English

Mechanism of HMG-CoA Reductase Inhibitor-Induced Contractile Dysfunction in Rat Cultured Skeletal Muscle

Biophysical Journal

English

Acute Hyperinsulinism Modulates Plasma Apolipoprotein B-48 Triglyceride--Rich Lipoproteins in Healthy Subjects During the Postprandial Period

Internal Medicine

English

Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Antimetastatic and Antitumorigenic Effects in Endometrial Cancer

Gynecologic Oncology

English

Fluvastatin, an HMG-CoA Reductase Inhibitor, Protects LDL From Oxidative Modification in Hypercholesterolemic Rabbits.

Biological and Pharmaceutical Bulletin

Pharmaceutical Science

English

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia

The Journal of Japan Atherosclerosis Society

English